These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Equalization of spread of breast cancer chemotherapy regimen at general hospitals--with EC and FEC regimens]. Kitada N, Nakayama T, Morita S, Sasaoka H, Yamasaki H, Anami S, Tatsuta M, Furukawa H, Morimoto S, Miyabe T, Hasegawa K, Tabuse K, Takara K, Yokoyama T, Watari M. Gan To Kagaku Ryoho; 2008 Feb; 35(2):267-71. PubMed ID: 18281763 [Abstract] [Full Text] [Related]
5. [High incidence-rate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy (FEC100)]. Fukazawa M, Kawaguchi H, Shigematsu H, Koga C, Mori E, Nishimura S, Nakamura Y, Satou S, Sawamura K, Kashiwaba K, Ohno S. Gan To Kagaku Ryoho; 2012 Mar; 39(3):395-8. PubMed ID: 22421766 [Abstract] [Full Text] [Related]
9. [Evaluation of host immunity and side effects in breast cancer patients treated with adjuvant chemotherapy (FEC therapy)]. Nagashima Y, Sanpei N, Yamamoto S, Yoshino S, Tangoku A, Oka M. Gan To Kagaku Ryoho; 2005 Oct; 32(11):1550-2. PubMed ID: 16315865 [Abstract] [Full Text] [Related]
10. A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer. Pacchiarotti I, Mazzarini L, Pellegrini P, Venturelli V, Sani G, Sánchez-Moreno J, Mancinelli I, Tatarelli R, Kotzalidis GD, Girardi P. Gen Hosp Psychiatry; 2007 Oct; 29(5):461-3. PubMed ID: 17888816 [Abstract] [Full Text] [Related]
11. [A patient with advanced breast cancer who developed bacterial meningitis after chemotherapy]. Shibata K, Suzuki A, Suzuki T, Sato T, Yamagishi T, Kimura S, Kimura W. Gan To Kagaku Ryoho; 2014 Jun; 41(6):769-71. PubMed ID: 25129092 [Abstract] [Full Text] [Related]
12. [Adjuvant epirubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study]. Saimura M, Mitsuyama S, Anan K, Tanaka M, Shimada K, Hirose N, Ogawa S, Tamaki N, Tomisaki S, Tamura K. Gan To Kagaku Ryoho; 2008 Sep; 35(9):1519-23. PubMed ID: 18799904 [Abstract] [Full Text] [Related]
13. Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity. Zachariae R, Paulsen K, Mehlsen M, Jensen AB, Johansson A, von der Maase H. Psychother Psychosom; 2007 Sep; 76(6):376-84. PubMed ID: 17917474 [Abstract] [Full Text] [Related]
14. [A case of advanced breast cancer leading to DIC after chemotherapy]. Ishizuka S, Morikawa T, Yoshida K, Nobuhisa T, Endo Y, Watanabe T, Matsumoto Y, Doi Y, Yamada T, Kai K, Nakashima A, Nagahiro I, Sato S, Nakashima A, Nabeyama A. Gan To Kagaku Ryoho; 2007 Nov; 34(11):1845-8. PubMed ID: 18030021 [Abstract] [Full Text] [Related]
16. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide. Shih V, Wan HS, Chan A. Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584 [Abstract] [Full Text] [Related]
17. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. Ryberg M, Nielsen D, Cortese G, Nielsen G, Skovsgaard T, Andersen PK. J Natl Cancer Inst; 2008 Aug 06; 100(15):1058-67. PubMed ID: 18664656 [Abstract] [Full Text] [Related]
18. [Clinicopathological evaluation of preoperative chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel for locally advanced breast cancer]. Miyake T, Miyahara S, Fujii K, Taniguchi M, Yamamura K, Tadokoro K, Tanimura M, Nakamura H. Gan To Kagaku Ryoho; 2009 Mar 06; 36(3):401-5. PubMed ID: 19295263 [Abstract] [Full Text] [Related]